Wegovy HD (Semaglutide 7.2 mg): FDA Approval, STEP UP Trial Data, and What It Means for Weight Loss Treatment
Wegovy HD (semaglutide 7.2 mg) launched in the U.S. this week after FDA approval in just 54 days. The STEP UP trial showed 20.7% mean weight loss — with 1 in 3 patients losing 25% or more of body weight.